Skip to main content

Gabify

Category: AI in Healthcare

An AI-powered health-tech platform specializing in early screening, diagnosis, and therapy management for neurodevelopmental disorders such as Autism, ADHD, and speech delays. Gabify was founded in 2023. The company is led by Sahil Chopra. Based in New Delhi, India. Team size: 11-50. Total funding raised: $205,000. Latest round: Pre-Seed. Key investors include ["Inflection Point Ventures (IPV)","GHRTBI Foundation"].

Founded
2023
Headquarters
New Delhi, India
Team size
11-50
Total funding
$205,000

Value proposition

Bridges the gap in neurodevelopmental care by providing accessible, affordable, and rapid AI-driven screening tools that reduce the time to diagnosis and streamline therapy management.

Products and solutions

["Neurolens: A multi-modal AI screening tool utilizing voice and vision analysis.","Connect by Gabify: A SaaS platform for therapists and institutions to automate session tracking and therapy planning.","AI-Powered Virtual Therapist: Automated support for speech and neuro-care exercises.","Clinical Progress Dashboards: Real-time milestone tracking and AI-generated child reports."]

Unique value

Utilizes a 'Dual-AI' approach (voice + vision) to analyze 189+ clinically validated criteria aligned with DSM-5 and CARS in a non-invasive 5-minute screening process.

Target customer

Parents and families, pediatricians, therapy centers, schools, and NGOs.

Industries served

["Healthcare (HealthTech)","Education (EdTech/Special Education)","Social Impact (NGOs)"]

Technology advantage

Combines multi-modal AI (facial expressions, eye gaze, and speech patterns) with a Human-in-the-Loop (HITL) validation model to ensure clinical accuracy while maintaining scalability.

How they differentiate

Utilizes a 'Dual-AI' approach (simultaneous voice and vision analysis) to provide a non-invasive, 5-minute screening process aligned with DSM-5 and CARS standards, integrated with a SaaS platform for end-to-end therapy management.

Main competitors

["CogniAble","Butterfly Learnings","Cognoa"]

Key partnerships

["Inflection Point Ventures (IPV)","Nidhi Seed Support Scheme (GHRTBI Foundation)","DreamDeal (Initiative by Anupam Mittal)","Network of 35+ preschools and daycare centers for pilot adoption"]

Notable customers

["35+ Preschools and Daycare Centers (Pilot Partners)","Specialized Therapy Centers"]

Major milestones

["Founded in 2023 to address the gap in neurodevelopmental care in India","Awarded Rs 25 Lakh under the Nidhi Seed Support Scheme (GHRTBI Foundation)","Developed 'Neurolens', an AI-powered multi-modal screening tool","Raised $175,000 Pre-Seed funding led by Inflection Point Ventures in April 2025"]

Growth metrics

Pilot adoption across a network of 35+ preschools and daycare centers; AI model trained on 189+ clinically validated criteria.

Market positioning

Early-stage HealthTech disruptor focusing on affordable and accessible early-intervention screening for neurodevelopmental disorders.

Geographic focus

India (Primary), with a focus on urban preschool and healthcare networks.

Patents and IP

Proprietary AI technology stack; no specific registered patents disclosed as of latest update.

About Sahil Chopra

Sahil Chopra is a serial entrepreneur and former investment professional with over 12 years of experience. Before founding Gabify, he served as an Associate and Senior Associate at Inflection Point Ventures (IPV) for two years, gaining deep insights into the startup ecosystem. He has a legal background, having worked with top-tier Indian law firms including Saraf and Partners and Krida Legal. He also founded a travel networking startup during his time in law school.

Official website: